Raiffeisen Bank International AG Invests $1.71 Million in Core Laboratories Inc. (NYSE:CLB)

Raiffeisen Bank International AG acquired a new stake in Core Laboratories Inc. (NYSE:CLB - Free Report) in the 4th quarter, according to its most recent disclosure with the SEC. The fund acquired 99,963 shares of the oil and gas company's stock, valued at approximately $1,706,000. Raiffeisen Bank International AG owned approximately 0.21% of Core Laboratories at the end of the most recent reporting period.

A number of other institutional investors have also recently modified their holdings of the stock. Point72 Asset Management L.P. acquired a new position in Core Laboratories in the fourth quarter valued at about $266,000. ProShare Advisors LLC bought a new stake in shares of Core Laboratories during the 4th quarter worth approximately $245,000. Quantinno Capital Management LP bought a new stake in shares of Core Laboratories during the 4th quarter worth approximately $195,000. Millennium Management LLC boosted its position in shares of Core Laboratories by 429.0% during the 4th quarter. Millennium Management LLC now owns 65,616 shares of the oil and gas company's stock worth $1,136,000 after acquiring an additional 53,213 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Core Laboratories by 3.7% in the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 26,723 shares of the oil and gas company's stock valued at $463,000 after acquiring an additional 960 shares during the last quarter. 97.81% of the stock is currently owned by institutional investors.

Core Laboratories Price Performance

Core Laboratories stock traded down $0.31 during mid-day trading on Thursday, reaching $10.82. The company had a trading volume of 74,823 shares, compared to its average volume of 402,643. The business has a fifty day simple moving average of $12.79 and a 200 day simple moving average of $16.32. The company has a market cap of $507.04 million, a P/E ratio of 16.46, a P/E/G ratio of 0.99 and a beta of 1.45. Core Laboratories Inc. has a fifty-two week low of $10.14 and a fifty-two week high of $25.13. The company has a current ratio of 2.32, a quick ratio of 1.71 and a debt-to-equity ratio of 0.49.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The firm had revenue of $123.59 million during the quarter, compared to the consensus estimate of $125.09 million. Core Laboratories had a net margin of 5.99% and a return on equity of 16.24%. The firm's revenue was down 4.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.19 earnings per share. On average, equities research analysts predict that Core Laboratories Inc. will post 0.96 earnings per share for the current year.

Core Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th will be paid a $0.01 dividend. This represents a $0.04 annualized dividend and a dividend yield of 0.37%. The ex-dividend date of this dividend is Monday, May 5th. Core Laboratories's dividend payout ratio is currently 6.78%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Stifel Nicolaus lowered their price objective on shares of Core Laboratories from $19.00 to $15.00 and set a "hold" rating for the company in a research report on Tuesday, April 15th. Wall Street Zen cut Core Laboratories from a "hold" rating to a "sell" rating in a report on Friday, April 25th. Finally, Citigroup decreased their target price on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Two equities research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $15.00.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.